Terms: = Prostate cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1 AND Staging
4 results:
1. Development and Validation of an Improved Pathological Nodal staging System in Men with prostate cancer.
Daskivich TJ; Luu M; Freedland SJ; Sandler H; Spratt DE; Zumsteg ZS
J Urol; 2022 Mar; 207(3):581-591. PubMed ID: 34694160
[TBL] [Abstract] [Full Text] [Related]
2. Pelvic lymph node dissection and its extent on survival benefit in prostate cancer patients with a risk of lymph node invasion >5%: a propensity score matching analysis from SEER database.
Chen J; Wang Z; Zhao J; Zhu S; Sun G; Liu J; Zhang H; Zhang X; Shen P; Shi M; Zeng H
Sci Rep; 2019 Nov; 9(1):17985. PubMed ID: 31784574
[TBL] [Abstract] [Full Text] [Related]
3. The role of magnetic resonance image guided prostate biopsy in stratifying men for risk of extracapsular extension at radical prostatectomy. Raskolnikov D, George AK, Rais-Bahrami S, Turkbey B, Siddiqui MM, Shakir NA, Okoro C, Rothwax JT, Walton-Diaz A, Sankineni S, Su D, Stamatakis L, Merino MJ, Choyke PL, Wood BJ, pinto PA. Urologic Oncology Branch, National cancer Institute, National Institutes of Health, Bethesda, Maryland; Molecular Imaging Program, National cancer Institute, National Institutes of Health, Bethesda, Maryland; Laboratory of Pathology, National cancer Institute, National Institutes of Health, Bethesda, Maryland; Center for Interventional Oncology, National cancer Institute & Clinical Center, National Institutes of Health, Bethesda, Maryland; Urologic Oncology Branch, National cancer Institute, National Institutes of Health, Bethesda, Maryland; Center for Interventional Oncology, National cancer Institute & Clinical Center, National Institutes of Health, Bethesda, Maryland; e-mail: pintop@mail.nih.gov.J Urol. 2015 Jul;194(1):105-11. [Epub 2015 Jan 23]. doi: 10.1016/j.juro.2015.01.072.
Scott E
Urol Oncol; 2017 Mar; 35(3):121. PubMed ID: 28159491
[TBL] [Abstract] [Full Text] [Related]
4. Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Lief JH; Allen Z; Adamovich E
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):32-43. PubMed ID: 15629591
[TBL] [Abstract] [Full Text] [Related]
